28th September 2016, London: ClinTec International (ClinTec) is celebrating being awarded Scale-Up Business of the Year, with founder and CEO Dr Rabinder Buttar also honoured as a finalist for Entrepreneur of the Year at the 5th Minority Supplier Development Network UK’s (MSDUK) awards ceremony.
This glamorous event was hosted by renowned British television comedian and playwright Meera Syal, with Paralympics presenter and wheelchair basketball player Ade Adepitan giving the keynote speech. This was attended by top pharmaceutical organisations GlaxoSmithKline, Bristol Myers Squibb, Merck Sharp & Dohme and other diverse organisations, including IBM and Coca-Cola.
The Scale-Up Business of the Year award, sponsored by Ernst and Young, recognises ClinTec’s dynamic and entrepreneurial emergence on to the global stage as a Clinical Research Organisation (CRO) and Functional Service Provider (FSP). Earlier at the MSDUK annual conference, Dr Buttar took part in a panel discussion, sponsored by Coca-Cola, on how to Scale-Up a business.
With capabilities in over 80 countries, ClinTec delivers innovative, customised clinical research solutions and talented functional services to the clinical development sector in a fast, flexible and focused way. ClinTec provides services to seven of the world’s top 10 pharmaceutical companies, leading mid-market biopharmaceutical organisations, as well as small and medium-sized biotechnology companies. ClinTec’s entrepreneurial solutions stem from the organisation’s focus on delivering not only what the customers require now, but what they will require to meet industry challenges in the future.
Dr Buttar said, “I am thrilled to accept this prestigious award on behalf of ClinTec International in recognition of our ongoing expansion both in service lines and in geographical reach. As founder of the organisation, I have always believed that further success comes from the early recognition not only of what our clients want today, but also will want in the future, and then having the courage to build my company along those lines with the support of my team. Embracing diversity has always been a core pillar of ClinTec in building and developing a global team of experts in clinical research. This award endorses that approach and also recognises the major contributions made by ClinTec’s management team and staff in building for our future success. This endorsement puts our achievements on the map and enhances our reputation with current and future clients.”
This new award highlights ClinTec’s successful year after being named Best Mid-Sized Pharmaceutical CRO in the UK by Global Health and Pharma (GHP) Magazine’s International Life Science Awards in June 2016 and as a finalist in the International Business and Export category at the Scottish Life Science awards in February 2016.
